Neoadiuvant treatment with intravesical interleukin-2 for recurrent superficial transitional bladder carcinoma Ta-T1/G1-2

被引：12

作者：

Grasso, M

Torelli, F

Scannapieco, G

Franzoso, F

Lania, C

机构：

[1] Desio Hosp, Dept Urol, Milan, Italy

[2] San Raffaele Inst, Milan, Italy

来源：

JOURNAL OF IMMUNOTHERAPY | 2001年 / 24卷 / 02期

关键词：

interleukin-2; immunotherapy; bladder cancer;

D O I：

10.1097/00002371-200103000-00013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The aim of this study was to evaluate the direct action of IL-2 on recurrent superficial transitional bladder carcinoma and the effect on recurrence rate. 27 patients were submitted to neoadjuvant treatment by intra-vesical instillation of recombinant IL-2 and to transurethral resection. We did not observe any effect on neoplasms but the recurrence rate was less than the expected one. It is possible that treatment of bladder carcinoma with intra-vesical instillation of IL-2 may promote immuno-prophilaxis.

引用

页码：184 / 187

页数：4

共 17 条

[1]

ALLARD P, 1996, CAN J UROL, V3, pA40

[2]

ANDRIOLE GL, 1990, J UROLOGY, V143, P310

[3] CANCER, CYTOKINES, AND CYTOTOXIC-CELLS - INTERLEUKIN-2 IN THE IMMUNOTHERAPY OF HUMAN NEOPLASMS [J].

ATZPODIEN, J ;

KIRCHNER, H .

KLINISCHE WOCHENSCHRIFT, 1990, 68 (01) :1-11

[4] METASTATIC MALIGNANT-MELANOMA TREATED WITH COMBINED BOLUS AND CONTINUOUS INFUSION INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS [J].

BAR, MH ;

SZNOL, M ;

ATKINS, MB ;

CIOBANU, N ;

MICETICH, KC ;

BOLDT, DH ;

MARGOLIN, KA ;

ARONSON, FR ;

RAYNER, AA ;

HAWKINS, MJ ;

MIER, JW ;

PAIETTA, E ;

FISHER, RI ;

WEISS, GR ;

DOROSHOW, JH .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (07) :1138-1147

[5] Intravesical interleukin-2 in T1 papillary bladder carcinoma: Regression of marker lesion in 8 of 10 patients [J].

Den Otter, W ;

Dobrowolski, Z ;

Bugajski, A ;

Papla, B ;

Van der Meijden, APM ;

Koten, JW ;

Boon, TA ;

Siedlar, M ;

Zembala, M .

JOURNAL OF UROLOGY, 1998, 159 (04) :1183-1186

[6] A PHASE-I STUDY OF INTRAVESICAL CONTINUOUS PERFUSION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH SUPERFICIAL BLADDER-CANCER [J].

FERLAZZO, G ;

MAGNO, C ;

LUPO, G ;

RIZZO, M ;

IEMMO, R ;

SEMINO, C ;

MELIOLI, G .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (02) :100-104

[7] METASTATIC RENAL-CANCER TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - A PHASE-II CLINICAL-TRIAL [J].

FISHER, RI ;

COLTMAN, CA ;

DOROSHOW, JH ;

RAYNER, AA ;

HAWKINS, MJ ;

MIER, JW ;

WIERNIK, P ;

MCMANNIS, JD ;

WEISS, GR ;

MARGOLIN, KA ;

GEMLO, BT ;

HOTH, DF ;

PARKINSON, DR ;

PAIETTA, E .

ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) :518-523

[8]

HULAND E, 1989, CANCER RES, V49, P5469

[9] FACTORS AFFECTING RECURRENCE AND PROGRESSION IN SUPERFICIAL BLADDER-TUMORS [J].

KURTH, KH ;

DENIS, L ;

BOUFFIOUX, C ;

SYLVESTER, R ;

DEBRUYNE, FMJ ;

PAVONEMACALUSO, M ;

OOSTERLINCK, W .

EUROPEAN JOURNAL OF CANCER, 1995, 31A (11) :1840-1846

[10] INTRACAVITARY ADMINISTRATION OF INTERLEUKIN-2 AS PALLIATIVE THERAPY FOR NEOPLASTIC EFFUSIONS [J].

LISSONI, P ;

BARNI, S ;

ARDIZZOIA, A ;

PAOLOROSSI, F ;

TISI, E ;

CRISPINO, S ;

TANCINI, G .

TUMORI, 1992, 78 (02) :118-120

← 1 2 →